Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5424526 | 1.00 | MAPT (0.61) | MAPTLMNADGKAKDM4EDUSP3 | |
| SCHEMBL28927790 | 1.00 | MAPT (0.61) | MAPTLMNADGKAKDM4EDUSP3 | |
| SCHEMBL28460470 | 1.00 | MAPT (0.61) | MAPTLMNADGKAKDM4EDUSP3 | |
| SCHEMBL1434319 | 1.00 | MAPT (0.61) | MAPTLMNADGKAKDM4EDUSP3 | |
| SCHEMBL1434473 | 1.00 | MAPT (0.61) | MAPTLMNADGKAKDM4EDUSP3 | |
| SCHEMBL27926557 | 1.00 | MAPT (0.61) | MAPTLMNADGKAKDM4EDUSP3 | |
| SCHEMBL157581 | 1.00 | MAPT (0.61) | MAPTLMNADGKAKDM4EDUSP3 | |
| SCHEMBL27952812 | 0.98 | MAPT (0.59) | MAPTLMNADGKAKDM4EDUSP3 | |
| SCHEMBL2254700 | 0.98 | MAPT (0.62) | MAPTLMNADGKAKDM4EDUSP3 | |
| SCHEMBL344802 | 0.98 | MAPT (0.62) | MAPTLMNADGKAKDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 389 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119604270-A | Comprising an antimicrobial agent accelerator composition | 西姆莱斯股份公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119161927-A | Composition for contact lens and method for maintaining contact lens | 晶硕光学股份有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-119031839-A | Compositions comprising an antimicrobial agent and an alkyl ketal ester compound | 西姆莱斯股份公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118512422-A | Burisperidone oral film-dissolving agent and preparation method thereof | 上海欣峰制药有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-118436602-A | External honokiol cream and preparation method and application thereof | 四川大学华西医院 | 2024-08-06 | — | — | CN | claimed |
| CN-117858620-A | Antimicrobial combinations | 西姆莱斯有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117813075-A | Preservative for cosmetic and pharmaceutical compositions | 赛成公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117752035-A | Method for removing purine from soybean plant protein powder and application | 黑河市坤鹏生物科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117460810-A | Transparent soap bar | 宝洁公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117398320-A | Composition for cleaning skin and preparation method and application thereof | 中国日用化学研究院有限公司 | 2024-01-16 | — | — | CN | claimed |
| US-7666828-B2 | Sulfonated estolides and other derivatives of fatty acids, methods of making them, and compositions and processes employing them | STEPAN COMPANY (US) | 2010-02-23 | — | — | US | claimed |
| US-20100017969-A1 | Sulfonated Estolide Compositions Containing Magnesium Sulfate and Processes Employing Them | STEPAN COMPANY | 2010-01-28 | — | — | US | claimed |
| US-20100016198-A1 | Compositions Comprising Sulfonated Estolides And Alkyl Ester Sulfonates, Methods Of Making Them, And Compositions And Processes Employing Them | STEPAN COMPANY | 2010-01-21 | — | — | US | claimed |
| US-20090188055-A1 | SULFONATED ESTOLIDES AND OTHER DERIVATIVES OF FATTY ACIDS, METHODS OF MAKING THEM, AND COMPOSITIONS AND PROCESSES EMPLOYING THEM | STEPAN COMPANY (US) | 2009-07-30 | — | — | US | claimed |
| WO-2009094336-A2 | SULFONATED ESTOLIDES AND OTHER DERIVATIVES OF FATTY ACIDS, METHODS OF MAKING THEM, AND COMPOSITIONS AND PROCESSES EMPLOYING THEM | STEPAN COMPANY (US) | 2009-07-30 | — | — | WO | claimed |
| EP-1286655-B1 | TOPICAL COMPOSITION CONTAINING AT LEAST ONE ARYL OXIME, AND METHOD FOR THE PREPARATION THEREOF | MERCK PATENT GMBH (DE) | 2006-09-13 | — | — | EP | claimed |
| US-20030176470-A1 | Topical composition containing at least one aryl oxime, and method for the preparation thereof | MERCK PATENT GMBH (DE) | 2003-09-18 | — | — | US | claimed |
| CN-1061085-C | skin cleansing composition | UNILEVER PLC (NL) | 2001-01-24 | — | — | CN | claimed |
| CN-1231593-A | Fatty acid esters of lactic acid salts as permeation enhancers | THERATECH INC (US) | 1999-10-13 | — | — | CN | claimed |
| CN-1146213-A | Skin cleansing composition | UNILEVER PLC (NL) | 1997-03-26 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176470-A1 | Topical composition containing at least one aryl oxime, and method for the preparation thereof | MGLL, LIPA, GLO1 | MAPT 3564/4885LMNA 1133/4885DGKA 123/4885 |
| US-20090188055-A1 | SULFONATED ESTOLIDES AND OTHER DERIVATIVES OF FATTY ACIDS, METHODS OF MAKING THEM, AND COMPOSITIONS AND PROCESSES EMPLOYING THEM | STS, ABHD16A, HDHD5 | MAPT 4781/4885LMNA 4267/4885DGKA 289/4885 |
| US-20100016198-A1 | Compositions Comprising Sulfonated Estolides And Alkyl Ester Sulfonates, Methods Of Making Them, And Compositions And Processes Employing Them | STS, ABHD16A, DEGS1 | MAPT 4083/4885LMNA 3322/4885DGKA 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.